T0	Outcomes 25 52	adjuvant tamoxifen response
T1	Outcomes 1114 1159	Oestrogen receptor positive ductal carcinomas
T2	Outcomes 1222 1246	recurrence free survival
T3	Outcomes 1523 1601	more complex, with a clear response in tumours with high and low proliferation
T4	Outcomes 1683 1690	poorly.